Quantitative Systematic Strategies’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,192
Closed -$1.36M 399
2021
Q2
$1.36M Sell
8,192
-4,555
-36% -$711K 0.47% 29
2021
Q1
$1.78M Sell
12,747
-10,648
-46% -$1.74M 0.28% 109
2020
Q4
$4.05M Buy
23,395
+3,728
+19% +$604K 0.57% 24
2020
Q3
$2.74M Sell
19,667
-2,488
-11% -$332K 0.48% 49
2020
Q2
$2.65M Buy
22,155
+14,528
+190% +$1.72M 0.52% 29
2020
Q1
$763K Buy
7,627
+3,773
+98% +$454K 0.62% 42
2019
Q4
$451K Buy
+3,854
New +$382K 0.07% 356
2018
Q3
Sell
-2,789
Closed -$223K 816
2018
Q2
$223K Buy
+2,789
New +$231K 0.04% 536
2017
Q3
Sell
-4,037
Closed -$293K 570
2017
Q2
$293K Buy
+4,037
New +$323K 0.07% 320
2017
Q1
Sell
-2,772
Closed -$202K 451
2016
Q4
$202K Sell
2,772
-960
-26% -$82.2K 0.08% 275
2016
Q3
$383K Buy
3,732
+58
+2% +$5.24K 0.14% 223
2016
Q2
$263K Sell
3,674
-602
-14% -$40.9K 0.12% 225
2016
Q1
$237K Sell
4,276
-7,119
-62% -$420K 0.09% 232
2015
Q4
$764K Buy
+11,395
New +$610K 0.21% 89

Other funds holding NVRO

Quantitative Systematic Strategies's NVRO Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of NEVRO CORP. (NVRO) in Q3 2021, closing a stake of 8,192 shares — an estimated $1.36M sold.

Quantitative Systematic Strategies first reported a position in NVRO in Q4 2015 and held it in 14 quarters. The position peaked at $4.05M in Q4 2020. 194 funds tracked by Wall St. Rank hold NVRO as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining NEVRO CORP. position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 8,192 NEVRO CORP. shares in Q3 2021, an estimated $1.36M.
  • Quantitative Systematic Strategies first reported a position in NEVRO CORP. in Q4 2015 and held it in 14 quarters.
  • Quantitative Systematic Strategies's NEVRO CORP. position peaked at $4.05M in Q4 2020.
  • 194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.